James B. Hermiller, MD, FACC, FSCAI

Original Contribution

A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients

02/24/2015

Nick Cavros , MD;

Nilesh J. Goswami , MD;

Wayne Leimbach , MD;

Roger Gammon , MD;

Steven P. Karas , MD;

John McCabe , MD;

Richard Paulus , MD;

James B. Hermiller , MD, FACC, FSCAI;

Zoltan G. Turi , MD;

Shing-Chiu Wong , MD;

Srihari S. Naidu , MD;

Robert J. Whitbourn , MD, MBBS;

The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...

The RESPECT trial was a...

02/24/2015

Journal of Invasive Cardiology

Commentary

Contemporary Management of Vein Graft Disease

08/01/2008

James B. Hermiller , MD, FACC, FSCAI;

Despite the promise of new transcatheter technologies, 400,000 coronary artery bypass (CABG) surgeries are performed each year in the United States, the vast majority incorporating saphenous vein grafts (SVG) as conduits.1 Soon after...

Despite the promise of new...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis With Everolimus-Eluting Stents

09/06/2014

Kyung Woo Park , MD;

David Rutledge , PharmD;

Moo-Hyun Kim , MD, PhD;

Mitchell W. Krucoff , MD;

Ehtisham Mahmud , MD;

Hyo-Soo Kim , MD, PhD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

James B. Hermiller , MD, FACC, FSCAI;

Tae Yang , MD;

George D. Dangas , MD, PhD;

Xience V USA is a prospective multicenter registry evaluating outcomes in patients treated with EES. Here, we present the 12-month clinical outcomes in patients who received EES for the treatment of in-stent restenosis (ISR) and non-ISR.

Xience V USA is a prospective...

09/06/2014

Journal of Invasive Cardiology

Commentary

Contemporary Treatment of Small-Vessel Disease

08/01/2008

James B. Hermiller , MD, FACC, FSCAI;

Since the inception of coronary angioplasty, small vessel disease has been a particularly challenging subset to treat with percutaneous interventional therapies. Historically small vessel intervention has been complicated by a higher...

Since the inception of coronary...

08/01/2008

Journal of Invasive Cardiology

Commentary

Role of Enoxaparin in the Invasive Management of the ACS Patient

08/01/2008

James B. Hermiller , MD, FACC, FSCAI;

Compared to unfractionated heparin (UFH), enoxaparin has many advantages in the management of acute coronary syndromes (ACS). Rapidly and reliably absorbed after subcutaneous administration, enoxaparin has pharmacodynamic and pharmacokinetic...

Compared to unfractionated...

08/01/2008

Journal of Invasive Cardiology